Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Design of a muscle cell-specific expression vector utilising human vascular smooth muscle α-actin regulatory elements

Gene Therapy volume 6, pages 616–628 (1999)Cite this article

Abstract

The facility to direct tissue-specific expression of therapeutic gene constructs is desirable for many gene therapy applications. We describe the creation of a muscle-selective expression vector which supports transcription in vascular smooth muscle, cardiac muscle and skeletal muscle, while it is essentially silent in other cell types such as endothelial cells, hepatocytes and fibroblasts. Specific transcriptional regulatory elements have been identified in the human vascular smooth muscle cell (VSMC) α-actin gene, and used to create an expression vector which directs the expression of genes in cis to muscle cells. The vector contains an enhancer element we have identified in the 5′ flanking region of the human VSMC α-actin gene involved in mediating VSMC expression. Heterologous pairing experiments have shown that the enhancer does not interact with the basal transcription complex recruited at the minimal SV40 early promoter. Such a vector has direct application in the modulation of VSMC proliferation associated with intimal hyperplasia/restenosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. CABRI. First-year results of CABRI (Coronary angioplasty versus bypass revascularisation investigation) Lancet 1995 346: 1179–1183

  2. The Bypass Angioplasty Revascularisation Investigation (BARI) Investigators . Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease New Engl J Med 1996 335: 217–225

    Article  Google Scholar 

  3. Califf RM . Restenosis: the cost to society Am Heart J 1995 130: 680–684

    Article  CAS  Google Scholar 

  4. Forrester JS et al. A paradigm for restenosis based on cell biology: clues for the development of new preventative therapies J Am Coll Cardiol 1991 17: 758–769

    Article  CAS  Google Scholar 

  5. Mattsson E, Clowes AW . Current concepts in restenosis following balloon angioplasty Trends Cardiovasc Med 1995 5: 200–204

    Article  CAS  Google Scholar 

  6. Casscells W, Engler D, Willerson JT . Mechanisms of restenosis Texas Heart Inst J 1994 21: 68–77

    CAS  Google Scholar 

  7. Guzman RJ et al. In vivo suppression of injury induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene Proc Natl Acad Sci USA 1994 91: 10732–10736

    Article  CAS  Google Scholar 

  8. Maillard L et al. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty Cardiovasc Res 1997 35: 536–546

    Article  CAS  Google Scholar 

  9. Chang MW et al. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty J Clin Invest 1995 96: 2260–2268

    Article  CAS  Google Scholar 

  10. Ohno T et al. Combination gene transfer to potentiate tumor regression Gene Therapy 1997 4: 361–366

    Article  CAS  Google Scholar 

  11. Chang MW et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science 1995 267: 518–522

    Article  CAS  Google Scholar 

  12. Sobue K, Sellers J . Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems J Biol Chem 1991 266: 12115–12118

    CAS  PubMed  Google Scholar 

  13. Byrne B et al. Chicken vinculin and meta-vinculin are derived from a single gene by alternative splicing of a 207-base pair exon unique to meta-vinculin J Biol Chem 1992 267: 12845–12850

    CAS  PubMed  Google Scholar 

  14. Owens GK, Thompson MM . Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation J Biol Chem 1986 261: 13373–13380

    CAS  PubMed  Google Scholar 

  15. Nagai R et al. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analyses J Biol Chem 1989 264: 9734–9737

    CAS  PubMed  Google Scholar 

  16. Maino JM, Olson EN . Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embyrogenesis J Biol Chem 1996 271: 7095–7103

    Article  Google Scholar 

  17. Herring BP, Smith AF . Telokin expression is mediated by a smooth muscle cell-specific promoter Am J Physiol 1996 270: C1656–C1665

    Article  CAS  Google Scholar 

  18. Nishida W, Kitami Y, Hiwada K . cDNA cloning and mRNA expression of calponin and SM22α in rat aorta smooth muscle cells Gene 1993 130: 297–302

    Article  CAS  Google Scholar 

  19. Moessler H et al. The SM22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice Development 1996 122: 2415–2425

    CAS  PubMed  Google Scholar 

  20. Murphy R . Muscle cells of hollow organs News Physiol Sci 1988 3: 124–128

    Google Scholar 

  21. Gabbiani G . The biology of the myofibroblast Kidney Int 1992 41: 530–532

    Article  CAS  Google Scholar 

  22. Ruzicka DL, Schwartz RJ . Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation J Biol Chem 1988 107: 2575–2586

    CAS  Google Scholar 

  23. Vandekerckhove J, Weber K . Actin typing on total cellular extracts: a highly sensitive protein-chemical procedure able to distinguish different actins Eur J Biochem 1981 113: 595–603

    Article  CAS  Google Scholar 

  24. Blank RS et al. Elements of the smooth muscle α-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation J Biol Chem 1992 267: 984–989

    CAS  PubMed  Google Scholar 

  25. McNamara CA et al. Nuclear proteins bind a cis-acting element in the smooth muscle alpha-actin promoter Am J Physiol 1995 268: C1259–C1266

    Article  CAS  Google Scholar 

  26. Simonson MS et al. Two proximal CArG elements regulate SM alpha-actin promoter, a genetic marker of activated phenotype of mesangial cells Am J Physiol 1995 268: F760–F769

    CAS  PubMed  Google Scholar 

  27. Shimizu RT et al. The smooth muscle α-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells J Biol Chem 1995 270: 7631–7643

    Article  CAS  Google Scholar 

  28. Foster DN et al. Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle α-actin gene J Biol Chem 1992 267: 11995–12003

    CAS  PubMed  Google Scholar 

  29. Cogan J et al. Plasticity of vascular smooth muscle alpha-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts J Biol Chem 1995 270: 11310–11321

    Article  CAS  Google Scholar 

  30. Min B, Foster DN . The 5′-flanking region of the mouse vascular smooth muscle α-actin gene contains evolutionary conserved sequence motifs within a functional promoter J Biol Chem 1990 27: 16667–16675

    Google Scholar 

  31. Bushel P et al. Two serum response elements mediate transcriptional repression of human smooth muscle α-actin promoter in ras-transformed cells Oncogene 1995 10: 1361–1370

    CAS  PubMed  Google Scholar 

  32. Reddy S et al. Structure of the human smooth muscle α-actin gene. Analysis of a cDNA and 5′ upstream region J Biol Chem 1990 265: 1683–1687

    CAS  PubMed  Google Scholar 

  33. Nakano Y et al. Transcriptional regulatory elements in the 5′ upstream and first intron regions of the human smooth muscle (aortic type) α-actin-encoding gene Gene 1991 99: 285–289

    Article  CAS  Google Scholar 

  34. Owens G, Vernon S, Madsen C . Molecular regulation of smooth muscle cell differentiation J Hypertens 1996 14: S55–S64

    Article  CAS  Google Scholar 

  35. Adachi Y, Kas E, Laemmli UK . Preferential, co-operative binding of topoisomerase II to scaffold associated regions EMBO J 1989 8: 3997–4006

    Article  CAS  Google Scholar 

  36. Izaurralde E, Kas E, Laemmli UK . Highly preferential nucleation of histone H1 assembly on scaffold associated regions J Mol Biol 1989 210: 573–585

    Article  CAS  Google Scholar 

  37. Owens GK . Regulation of differentiation of vascular smooth muscle cells Physiol Rev 1995 75: 487–517

    Article  CAS  Google Scholar 

  38. Courey AJ, Tijan R . Analysis of Sp1 in vivo reveals multiple transcriptional domains involving a novel glutamine rich activation motif Cell 1988 55: 887–898

    Article  CAS  Google Scholar 

  39. Aso T, Conaway J, Conaway R . Role of core promoter structure in assembly of the RNA polymerase II preinitiation complex. A common pathway for formation of preinitiation intermediates at many TATA and TATA-less promoters J Biol Chem 1994 269: 26575–26583

    CAS  PubMed  Google Scholar 

  40. Buratowski S . Multiple TATA-binding factors come back into style Cell 1997 91: 13–15

    Article  CAS  Google Scholar 

  41. Suzuki M, Singh RN, Crystal RG . Regulatable promoters for use in gene therapy applications: modification of the 5′-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP Hum Gene Ther 1996 7: 1883–1893

    Article  CAS  Google Scholar 

  42. Franz WM et al. Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters Cardiovasc Res 1997 35: 560–566

    Article  CAS  Google Scholar 

  43. Schmitt J et al. Dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation Gene Therapy submitted)

  44. Andrawis NS, Ruley EH, Abernethy DR . Angiotensin II regulates human vascular smooth muscle α-actin gene expression Biochem Biophys Res Commun 1993 196: 962–968

    Article  CAS  Google Scholar 

  45. Andrawis NS, Wang E, Abernethy DR . Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cells Life Sci 1996 59: 523–528

    Article  CAS  Google Scholar 

  46. Hautmann MB, Madsen CS, Owens GK . A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements J Biol Chem 1997 272: 10948–10956

    Article  CAS  Google Scholar 

  47. Keogh M-C et al. High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid–DNA complex Gene Therapy 1997 4: 162–171

    Article  CAS  Google Scholar 

  48. Iwaki K et al. Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response J Biol Chem 1990 265: 13809–13817

    CAS  PubMed  Google Scholar 

  49. Bhavsar PK et al. Isolation and characterisation of the human cardiac Troponin I gene (TNN13) Genomics 1996 35: 11–23

    Article  CAS  Google Scholar 

  50. Takahashi K et al. Spontaneous transformation and immortalization of human endothelial cells In Vitro Cell Dev Biol 1990 25: 265–274

    Article  Google Scholar 

  51. Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning. A Laboratory Manual, 2 edn Cold Harbor Laboratory Press: Cold Harbor, NY 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thrombosis Research Institute, London

    M-C Keogh, D Chen, J F Schmitt, U Dennehy, V V Kakkar & N R Lemoine

  2. Imperial Cancer Research Fund, Molecular Oncology Unit, Imperial College School of Medicine, London, UK

    N R Lemoine

Authors
  1. M-C Keogh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J F Schmitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U Dennehy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V V Kakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N R Lemoine
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keogh, MC., Chen, D., Schmitt, J. et al. Design of a muscle cell-specific expression vector utilising human vascular smooth muscle α-actin regulatory elements. Gene Ther 6, 616–628 (1999). https://doi.org/10.1038/sj.gt.3300866

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300866

Keywords

This article is cited by

Search

Advanced search

Quick links